US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
作者信息
Rappaport Mary
出版信息
J Oncol Pract. 2016 May;12(5):397. doi: 10.1200/JOP.2015.012872.
PMID:27170686
Abstract
摘要
相似文献
1
US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
J Oncol Pract. 2016 May;12(5):397. doi: 10.1200/JOP.2015.012872.
2
Perspectives on Cost and Value in Cancer Care.
JAMA Oncol. 2016 Jan;2(1):19-21. doi: 10.1001/jamaoncol.2015.4191.
3
The NHS: failing to deliver on Beveridge's promise?
Lancet Oncol. 2018 Jan;19(1):1. doi: 10.1016/S1470-2045(17)30918-X.
4
Value-based payment models in oncology: will they help or hinder patient access to new treatments?
Am J Manag Care. 2017 Apr;23(5 Spec No.):SP188-SP190.
5
Targeted immunotherapies overtaking emerging oncology market value based growth.
J BUON. 2015 Jan-Feb;20(1):350-1.
6
How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
Oncology (Williston Park). 2016 May;30(5):468-74.
7
Health policy: Putting a price on cancer.
Nat Rev Clin Oncol. 2016 Mar;13(3):137-8. doi: 10.1038/nrclinonc.2016.12. Epub 2016 Feb 9.
8
United healthcare, five oncology practices try bundled payments.
J Natl Cancer Inst. 2011 Jan 5;103(1):8-10. doi: 10.1093/jnci/djq538. Epub 2010 Dec 17.
9
The Cancer Drug Fund 1 year on--success or failure?
Lancet Oncol. 2012 Aug;13(8):754-7. doi: 10.1016/S1470-2045(12)70273-5. Epub 2012 Jun 29.
10
Confluence of Cultural Context and Technological Innovation to Reduce Cardiovascular Disparities in India.
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). doi: 10.1161/CIRCOUTCOMES.117.004081.
Zotero 插件